Yale New Haven Health System integrates ActX Genomic Decision Support in Epic EHR

Listen
Text
  • Small
  • Medium
  • Large

Yale New Haven (Conn.) Health System is adding a genomic decision support tool to its Epic EHR to improve its precision medicine efforts.

YNHHS will integrate ActX  Genomic Decision Support at its five hospitals and over 400 ambulatory sites, including its 1,541-bed academic medical center.

The ActX platform aims to help prescribers check prescription drugs against a patient's genetic profile. With the clinical decision support tool, prescribers will receive alerts within their Epic workflow related to potential adverse reactions, drug efficacy or dosing.

YNHHS will initially focus its genomic decision support on pharmacogenomics in behavioral health, cardiology, infectious disease and pediatrics.

More articles on data analytics & precision medicine: 

Wisconsin researchers awarded $5.3M for NIH All of Us program

Chicagoland hospital to offer genetic testing as part of an annual checkup

Illumina Accelerator, Helix team up to develop direct-to-consumer genomics products

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars